Abstract:Metal-organic frameworks (MOFs), which are typically embedded in polymer matrices as composites, are emerging as a new class of carriers for sustained drug delivery. Most of the MOFs and the polymers used so far in these composites, however, are not pharmaceutically acceptable. In the investigation reported herein, composites of γ-cyclodextrin (γ-CD)-based MOFs (CD-MOFs) and polyacrylic acid (PAA) were prepared by a solid in oil-in-oil (s/o/o) emulsifying solvent evaporation method. A modified hydrothermal protocol has been established which produces efficiently at 50 °C in 6 h micron (5-10 μm) and nanometer (500-700 nm) diameter CD-MOF particles of uniform size with smooth surfaces and powder X-ray diffraction patterns that are identical with those reported in the literature. Ibuprofen (IBU) and Lansoprazole (LPZ), both insoluble in water and lacking in stability, were entrapped with high drug loading in nanometer-sized CD-MOFs by co-crystallisation (that is more effective than impregnation) without causing MOF crystal degradation during the loading process. On account of the good dispersion of drug-loaded CD-MOF nanocrystals inside polyacrylic acid (PAA) matrices and the homogeneous distribution of the drug molecules within these crystals, the composite microspheres exhibit not only spherical shapes and sustained drug release over a prolonged period of time, but they also demonstrate reduced cell toxicity. The cumulative release rate for IBU (and LPZ) follows the trend: IBU-γ-CD complex microspheres (ca. 80% in 2 h) > IBU microspheres > IBU-CD-MOF/PAA composite microspheres (ca. 50% in 24 h). Importantly, no burst release of IBU (and LPZ) was observed from the CD-MOF/PAA composite microspheres, suggesting an even distribution of the drug as well as strong drug carrier interactions inside the CD-MOF. In summary, these composite microspheres, composed of CD-MOF nanocrystals embedded in a biocompatible polymer (PAA) matrix, constitute an efficient and pharmaceutically acceptable MOF-based carrier for sustained drug release.

Cyclodextrin-based Metal-Organic Frameworks Particles As Efficient Carriers for Lansoprazole: Study of Morphology and Chemical Composition of Individual Particles

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Enhanced Dissolution and Stability of Lansoprazole by Cyclodextrin Inclusion Complexation: Preparation, Characterization, and Molecular Modeling

Inclusion Complexation of Lansoprazole with Cyclodextrin Derivatives by 1H NMR, UV Spectroscopy and Phase Solubility

Cyclodextrin metal-organic framework@SiO2 nanocomposites for poorly soluble drug loading and release

Composite CD-MOF Nanocrystals-Containing Microspheres for Sustained Drug Delivery

Cyclodextrin-based metal-organic frameworks transforming drug delivery

Crosslinked γ-cyclodextrin metal organic framework for stable ibuprofen loading

Investigation of pantoprazole loading and release from a magnetic-coated chitosan-modified zirconium-based metal-organic framework (MOF) as a nanocarrier in targeted drug delivery systems

A Zirconium-Based Metal-Organic Framework with Encapsulated Anionic Drug for Uncommonly Controlled Oral Drug Delivery

CD-MOFs: From preparation to drug delivery and therapeutic application

Cyclodextrin-Based Metal-Organic Frameworks (CD-MOFs) in Pharmaceutics and Biomedicine

Cyclodextrin-based metal-organic framework materials: Classifications, synthesis strategies and applications in variegated delivery systems

Chitosan Modified Metal–organic Frameworks As a Promising Carrier for Oral Drug Delivery

Cyclodextrin Metal-Organic Frameworks as a Drug Delivery System for Selected Active Pharmaceutical Ingredients

Functionalization of Mixed Ligand Metal-Organic Frameworks As the Transport Vehicles for Drugs.

Controllable Porosity Conversion of Metal-Organic Frameworks Composed of Natural Ingredients for Drug Delivery

A γ-cyclodextrin-based metal–organic framework (γ-CD-MOF): a review of recent advances for drug delivery application

An Easy Approach towards Once a Day Sustained Release Dosage Form using Microporous Cu-MOFs as Drug Delivery Vehicle

Outstanding Drug-Loading/Release Capacity of Hollow Fe-Metal-Organic Framework-Based Microcapsules: A Potential Multifunctional Drug-Delivery Platform.

A Low Cytotoxic Cationic Metal-Organic Framework Carrier for Controllable Drug Release